ADDISON, Texas, July 8 /PRNewswire-FirstCall/ -- ULURU Inc. today announced that it has scheduled a conference call to provide an update on a recent development, Wednesday, July 9, 2008 at 10:00 a.m. Eastern time.
To participate in the conference call, please dial (800) 357-0498 for international callers dial (850) 429-1388 (access code 9294#) five to ten minutes prior to the initiation of the teleconference. If you are unable to listen to the live broadcast a replay of the call will be available starting on July 9, 2008 two hours following the end of the call until July 16, 2008 at 11:59 p.m. Eastern Time. For the U.S. replay, please dial (800) 695-0697 for international callers dial (402) 220-1472 (access code 9294#).
About ULURU Inc.:
ULURU Inc. is an emerging specialty pharmaceutical company focused on the development of a portfolio of wound management, plastic surgery and oral care products to provide patients and consumers improved clinical outcomes through controlled delivery utilizing its innovative transmucosal delivery system and Hydrogel Nanoparticle Aggregate technology. For further information about ULURU Inc., please visit our website at http://www.uluruinc.com.
This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended. These statements are subject to numerous risks and uncertainties, including but not limited to the risk factors detailed in the Company's Annual Report on Form 10-KSB for the year ended December 31, 2007 and other reports filed by us with the Securities and Exchange Commission.
CONTACT: Kerry P. Gray, President & CEO, or Terry K. Wallberg, Vice
President & CFO, both of ULURU Inc., +1-214-905-5145
Web site: http://www.uluruinc.com/
